Shigehiko Kitano
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 34
- Glaucoma and retinal disorders 20
- Intraocular Surgery and Lenses 4
-
- Retinal Imaging and Analysis 24
- Retinal and Macular Surgery 4
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 4
-
- Connexins and lens biology 3
-
- Chronic Kidney Disease and Diabetes 3
- Co-authors
- Satoshi KatoHideharu FunatsuHidetoshi YamashitaSadao HoriYasuko UchigataJoseph CaprioliJames P. MorganTomohiro Ikeda
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Shigehiko Kitano
43 papers receiving 895 citations
Peers
Comparison fields: 5 of 73
- Ophthalmology 716
- Radiology, Nuclear Medicine and Imaging 459
- Clinical Biochemistry 75
- Neurology 32
- Molecular Biology 252
Countries citing papers authored by Shigehiko Kitano
This map shows the geographic impact of Shigehiko Kitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiko Kitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiko Kitano more than expected).
Fields of papers citing papers by Shigehiko Kitano
This network shows the impact of papers produced by Shigehiko Kitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiko Kitano. The network helps show where Shigehiko Kitano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shigehiko Kitano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2021 | 12 | |
| 4 | 2019 | 13 | |
| 5 | 2019 | 15 | |
| 6 | 2018 | 5 | |
| 7 | 2017 | 40 | |
| 8 | 2017 | 37 | |
| 9 | Screening for diabetic retinopathy using RETevalTM, new mydriasis-free full-field ERG recording system | 2016 | 2 |
| 10 | 2016 | 58 | |
| 11 | 2016 | 19 | |
| 12 | 2013 | 1 | |
| 13 | 2005 | 10 | |
| 14 | 2005 | 12 | |
| 15 | 2004 | 18 | |
| 16 | 2003 | 4 | |
| 17 | 2002 | 13 | |
| 18 | 2002 | 139 | |
| 19 | 2001 | 67 | |
| 20 | 1996 | 74 |
About Shigehiko Kitano
Shigehiko Kitano is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Clinical Biochemistry, having authored 46 papers that have together received 930 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (34 papers), Retinal Imaging and Analysis (24 papers), Glaucoma and retinal disorders (20 papers), Retinal and Macular Surgery (4 papers), Intraocular Surgery and Lenses (4 papers), Advanced Glycation End Products research (4 papers), Connexins and lens biology (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Ophthalmology (716 citations), Radiology, Nuclear Medicine and Imaging (459 citations) and Clinical Biochemistry (75 citations). Shigehiko Kitano has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Satoshi Kato, Hideharu Funatsu, Hidetoshi Yamashita, Sadao Hori, Yasuko Uchigata, Joseph Caprioli, James P. Morgan, Tomohiro Ikeda, Harumi Fukushima and Yasuhiko Iwamoto. Their work appears in journals such as PLoS ONE, Diabetes Care and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.